“Hofmann et al – 2020 – A multi-analyte approach for improved sensitivity”
Lilli Hofmann 1,2, Katja Sallinger 1,2, Christoph Haudum 2,3 , Maria Smolle 4 ,
Ellen Heitzer 5,6,7 , Tina Moser 5, Michael Novy 8, Kevin Gesson 8, Thomas Kroneis 1,2,
Thomas Bauernhofer 9,y and Amin El-Heliebi 1,2,*,y

“Wang et al – 2020 – In vivo enrichment and elimination of CTCs”
Dou Wang, Chenchen Ge, Weiyuan Liang, Qinhe Yang, Quan Liu, Wei Ma, Lulin Shi,
Hong Wu, Yuhua Zhang, Zongze Wu, Chaoying Wei, Luodan Huang, Zhiyuan Fang,*
Liping Liu,* Shiyun Bao,* and Han Zhang*

“In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict
Prognosis in Patients with Metastatic Breast Cancer”
Ning Xie1 & Zheyu Hu1 & Can Tian1 & Huawu Xiao1 & Liping Liu1 & Xiaohong Yang1 & Jing Li1 & Hui Wu1 & Jun Lu1 &
Jianxiang Gao1 & Xuming Hu1 & Min Cao1 & Zhengrong Shui1 & Quchang Ouyang1

“Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays”
Budna-Tukan J, Świerczewska M, Mazel M, Cieślikowski WA, Ida A, Jankowiak A, Antczak A, Nowicki M, Pantel K, Azria D, Zabel M, Alix-Panabières C.
Cancers. 2019

“In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy”
Chen S, Tauber G, Langsenlehner T, Schmölzer LM, Pötscher M, Riethdorf S, Kuske A, Leitinger G, Kashofer K, Czyż ZT, Polzer B, Pantel K, Sedlmayr P, Kroneis T, El-Heliebi A.
Cancers. 2019

“In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.”
El-Heliebi A, Hille C, Laxman N, Svedlund J, Haudum C, Ercan E, Kroneis T, Chen S, Smolle M, Rossmann C, Krzywkowski T, Ahlford A, Darai E, von Amsberg G, Alsdorf W, König F, Löhr M, de Kruijff I, Riethdorf S, Gorges TM, Pantel K, Bauernhofer T, Nilsson M, Sedlmayr P
Clin Chem. 2018
Jan 4. pii: clinchem.2017.281295. doi: 10.1373/clinchem.2017.281295

“Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH.”
Gallerani G, Cocchi C, Bocchini M, Piccinini F, Fabbri F
Vis Exp. 2017
Dec 21;(130). doi: 10.3791/56936.

“Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.”
Markou A, Lazaridou M, Paraskevopoulos P, Chen S, Swierczewska M, Budna J, Kuske A, Gorges TM, Joosse SA, Kroneis T, Zabel M, Sedlmayr P, Alix-Panabières C, Pantel K, Lianidou ES.
Clin Chem. 2017 Nov 9.
pii: clinchem.2017.275503. doi: 10.1373/clinchem.2017.275503.

“Enumeration and molecular characterization of circulating tumor cell using an in vivo capture system in squamous cell carcinoma of head and neck.”
Zhang H, Gong S, Liu Y, Liang L, He S, Zhang Q, Si M, Yu Z.
Chin J Cancer Res. 2017 Jun; 29(3):196-203
doi: 10.21147/j.issn.1000-9604.2017.03.05.

“Circulating tumor cells in patients with breast tumors were detected by a novel device: a multicenter, clinical trial in China”
Li JB, Geng CZ, Yan M, Wang YS, Ouyang QC, Yin YM, Wu LN, He J, Jiang ZF.
Zhonghua Yi Xue Za Zhi.
2017 Jun 27;97(24):1857-1861.
doi: 10.3760/cma.j.issn.0376-2491.2017.24.003.

“Highly Selective Capture Surfaces on Medical Wires for Fishing Tumor Cells in Whole Blood”
Scherag FD, Niestroj-Pahl R, Krusekopf S, Lücke K, Brandstetter T, Rühe J.
Anal Chem. 2017 Feb 7;89(3):1846-1854. doi: 10.1021/acs.analchem.6b04219. Epub 2017 Jan 12.

“A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours”
Endocr Relat Cancer. 2016 Oct;23(10):L29-32.
Epub 2016 Aug 12. No abstract available.
doi: 10.1530/ERC-16-0201.

“The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes – A Proof-of-Concept Study“
Theil G, Fischer K, Weber E, Medek R, Hoda R, Lücke K, Fornara P.
PLoS One. 2016 Aug 1;11(8):e0158354.
doi:10.1371/journal.pone.0158354.

“Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells“
Gorges TM, Penkalla N, Schalk T, Joosse SA, Riethdorf S, Tucholski J, Lücke K, Wikman H, Jackson S, Brychta N, von Ahsen O, Schumann C, Krahn T, Pantel K
Clin Cancer Res. 2016 May 1;22(9):2197-206.
doi:10.1158/1078-0432.CCR-15-1416. Epub 2015 Dec 14

“A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire”

Saucedo-Zeni N, Mewes S, Niestroj R, Gasiorowski L, Murawa D, Nowaczyk P, Tomasi T, Weber E, Dworacki G, Morgenthaler NG, Jansen H, Propping C, Sterzynska K, Dyszkiewicz W, Zabel M, Kiechle M, Reuning U, Schmitt M, Lücke K.

Int J Oncol. 2012 Oct;41(4):1241-50

doi: 10.3892/ijo.2012.1557

In vivo isolation of circulating tumor cells in different clinical settings for multiple downstream application

Monitoring of treatment response in NSCLC patients by enumeration of circulating tumor cells

Circulating Tumor Cells Spillage after Lung Nodule Biopsy  

An effective in vivo Liquid Biopsy tool for the isolation ofcirculating tumor cells in non-small cell lung cancer

Enumeration of circulating tumor cells in lung cancer patients using the GILUPI CellCollector^®

An effective in vivo Liquid Biopsy tool for high-yield isolation of circulating tumor cells

Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using an effective in vivo technology, the GILUPI CellCollector™

Circulating tumor cells isolated from non-small cell lung cancer patients using an effective in vivo technology, the GILUPI CellCollector® technology, the GILUPI CellCollector™

Enumeration & molecular characterization of circulating tumour cells in lung cancer patients using the GILUPI CellCollector^®, an effective in vivo device for capturing CTCs

A new medical device for in vivo fetal cells isolation from maternal blood -preliminary results of safety evaluation

Verification of a functionalized structured medical wire for the isolation of circulating tumor cells in patients with renal cell carcinoma

The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration – resistant prostate cancer

Comparison of circulating tumor cell capture efficiency of the CellCollector™ technology vs CellSearch^® in prostate cancer patients at multiple time points device for capturing CTCs

An innovative technology for in vivo isolation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients and immunofluorescent detection of ALK protein in prostate cancer patients at multiple time points device for capturing CTCs

A novel technology for in vivo isolation of circulating tumor cells in breast cancer patients in prostate cancer patients at multiple time points device for capturing CTCs

Isolation of circulating tumor cells in vivo by the CellCollector™ technology in prostate cancer patients at multiple time points device for capturing CTCs

An innovative approach for in vivo isolation of circulating tumor cells (CTCs)

In vivo isolation of circulating tumor cells in prostate cancer patients by a medical device

Verification of a functionalized structured medical wire for the isolation of circulating tumor cells in patients with renal cell carcinoma

In vivo isolation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients by a medical device

A new medical device for in vivo isolation of circulating tumor cells in prostate cancer patients

Functionalized and structured medical wire as a device for in vivo isolation of circulating tumor cells in breast cancer patients

 A new medical device for in-vivo isolation of circulating tumor cells in non small cell lung cancer (NSCLC) patients

In vivo Isolation of Circulating Tumor Cells

A new medical device for in vivo capturing of circulating tumor cells in breast cancer (BC) patients

Nanodetector for in vivo isolation of rare cells

GILUPI – we extract the cells you search for

In vivo Isolation of Circulating Tumor Cells